Founded in 2022, Sophrosyne Technologies operates in Advanced Hardware & Technology offering advanced healthcare technologies through its proprietary system-on-chip architecture. The company focuses o...
Funding stage:
Seed
Last funding:
20/11/2025
Total funding:
$2.00 Mn+
Revenue:
Investors
Employee count:
20
Last 90d
20
Last 90d
Sophrosyne Technologies: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders5
Latest Filing Date19 April 2026- Funding Events10
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Sophrosyne Technologies
As of 20 April 2026, Sophrosyne Technologies's equity is held by 4 shareholders, with the top three being Manish Srivastava, Jatin Gupta, and Bluehill Capital Fund I.
Manish Srivastava holds the largest stake in Sophrosyne Technologies at 40.6% as of 20 April 2026.
As of 20 April 2026, founders collectively hold 73.7% equity in Sophrosyne Technologies.
As of 20 April 2026, investors collectively hold 15.3% equity in Sophrosyne Technologies.
Sophrosyne Technologies's ESOP pool stands at 10.9% of total equity as of 20 April 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links